Find your clinic
Read more
Asclepion Web Club
Reserved area
Videos
Watch the treatments
Asclepion worldwide
Find your distributor
News
May 2008
New certifications
Asclepion is proud to announce, that with May 6th, the Dermablate Effect received the EC Declaration of Conformity according to the requirements of the medical device directive 93/42EEC Annex II. Asclepion is also working on the regulatory clearance to market in other countries, like the FDA approval.
Also the MeDioStar XT and miXT and its applications hair removal, vascular lesion, skin rejuvenation and acne treatment are now approved by Health Canada and thereby ready to be sold in Canada.
<< Back